Carcinoembryonic antigen (CEA) levels correlate with clinical progress in gastroenteric tumors, especially during chemotherapy. Monitoring CEA aids in assessing treatment effectiveness and guiding therapeutic decisions for gastric and colorectal cancers.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: